C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men

Circulation

Volumn 110, Issue 7, 2004, Pages 862-866

  Norman, Paul ^a,d   Spencer, Carole A ^a   Lawrence Brown, Michael M ^b   Jamrozik, Konrad ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Mount Hospital   (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d FREMANTLE HOSPITAL   (Australia)

Author keywords

Aneurysm; Aorta; Proteins; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE COURSE; ECHOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTHROPOMETRY; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING;

EID: 4143150882     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000138746.14425.00     Document Type: Article

References (32)

1. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428.
2. Ridker P. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet. 2001;358:946-948.
3. Ridker P, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
4. Powell J, Muller B, Greenhalgh R. Acute phase proteins in patients with abdominal aortic aneurysms. J Cardiovasc Surg. 1987;28:528-5230.
5. Juvonen J, Surcel H, Satta J, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997;17:2843-2847.
6. Vainas T, Lubbers T, Stassen F, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107:1103-1105.
7. Collaborative Aneurysm Screening Group. A comparative study of the prevalence of abdominal aortic aneurysms in the United Kingdom, Denmark and Australia. J Med Screen 2001;8:46-50.
8. Wilmink A, Hubbard C, Day N, et al. The incidence of small abdominal aortic aneurysms and the change in normal infrarenal aortic diameter: implications for screening. Eur J Vasc Endovasc Surg. 2001;21:165-170.
9. UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998;352:1649-1655.
10. Lederle F, Wison S, Johnson G, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437-1444.
11. Jamrozik K, Norman PE, Spencer CA, et al. Screening for abdominal aortic aneurysms: lessons from a population-based study. Med J Aust. 2000;173:345-350.
12. Leng G, Fowkes F. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45:1101-1109.
13. SAS. 8th ed. Cary, NC: Statistical Analysis System Institute Inc; 1999.
14. EGRET. Seattle, Wash: Statistics and Epidemiology Research Corporation; 1991.
15. SPSS. Statistical Package for the Social Sciences. 10th ed. Chicago, III: SPSS Inc; 1999.
16. Watson C, Walton J, Heather B, et al. What is the long-term outcome for patients with very small abdominal aortic aneurysms? Eur J Vasc Endovasc Surg. 1997;14:299-304.
17. Vardulaki K, Prevost T, Walker N, et al. Growth rates and risk of rupture of abdominal aortic aneurysms. Br J Surg. 1998;85:1674-1680.
18. Couto E, Duffy S, Ashton H, et al. Probabilities of progression of aortic aneurysms: estimates and implications for screening policy. J Med Screen. 2002;9:40-42.
19. Santilli S, Littooy F, Cambria R, et al. Expansion rates and outcomes for the 3.0 cm to the 3.9 cm infrarenal abdominal aortic aneurysm. J Vasc Surg. 2002;35:666-671.
20. MacSweeney STR, Ellis M, Worrell P, et al. Smoking and growth rate of small abdominal aortic aneurysms. Lancet. 1994;344:651-652.
21. Chang J, Stein T, Liu J, et al. Risk factors associated with rapid growth of small abdominal aortic aneurysms. Surgery. 1997;121:117-122.
22. Vardulaki K, Walker N, Day N, et al. Quantifying the risks of hypertension, age, sex, and smoking in patients with abdominal aortic aneurysm. Br J Surg. 2000;87:195-200.
23. Lederle F, Johnson G, Wilson S, et al. The aneurysm detection and management study screening program: validation cohort and final results. Arch Int Med. 2000;160:1425-1430.
24. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
25. Koch A, Haines G, Rizzo R, et al. Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol. 1990;137:1199-1213.
26. Newman K, Jean-Claude J, Ramey W, et al. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994;90(suppl II):11-224-11-227.
27. Domanovits H, Schillinger M, Mullner M, et al. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis. 2002;163:297-302.
28. Treska V, Topolcan O, Pecan L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med. 2000;38:1161-1164.
29. Jones K, Brull D, Brown L, et al. Interleukin-6 and the prognosis of abdominal aortic aneurysms. Circulation. 2001;103:2260-2265.
30. Freestone T, Turner R, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15:1145-1151.
31. Rohde L, Arroyo L, Rifai N, et al. Plasma concentrations of Interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol. 1999;19:1695-1699.
32. Albert M, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286:64-70.